Literature DB >> 21321361

Promotion and maintenance of leukemia by ERG.

Shinobu Tsuzuki1, Osamu Taguchi, Masao Seto.   

Abstract

The Ets-related gene (ERG) located on human chromosome 21 encodes a transcription factor and is thought to be causally related to Down syndrome-associated acute megakaryocytic leukemia in childhood. In clinical adult leukemia, however, increased expression of ERG is indicative of poor prognosis in T-cell acute lymphoblastic leukemia and cytogenetically normal acute myeloid leukemia, although the involvement of ERG in the development of adult leukemia remains elusive. Here, we show that forced expression of ERG in adult BM cells alters differentiation and induces expansion of T and erythroid cells and increases frequencies of myeloid progenitors in mouse BM transplantation models. The expanded T cells then develop T-cell acute lymphoblastic leukemia after acquisition of mutations in the Notch1 gene. Targeted expression of ERG into B cells also altered differentiation and promoted growth of precursor B cells. Overall, these findings suggest a general role of ERG in promoting growth of adult hematopoietic cells in various lineages. In line with this, shRNA-mediated silencing of ERG expression attenuated growth of human leukemia cell lines of various lineages. Thus, ERG is capable of promoting the development of leukemia and is crucial for its maintenance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21321361     DOI: 10.1182/blood-2010-11-320515

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia.

Authors:  M Zaliova; O Zimmermannova; P Dörge; C Eckert; A Möricke; M Zimmermann; J Stuchly; A Teigler-Schlegel; B Meissner; R Koehler; C R Bartram; L Karawajew; P Rhein; J Zuna; M Schrappe; G Cario; M Stanulla
Journal:  Leukemia       Date:  2013-09-27       Impact factor: 11.528

2.  Identifying candidate oocyte reprogramming factors using cross-species global transcriptional analysis.

Authors:  Jason P Awe; James A Byrne
Journal:  Cell Reprogram       Date:  2013-03-04       Impact factor: 1.987

3.  Insertional mutagenesis using the Sleeping Beauty transposon system identifies drivers of erythroleukemia in mice.

Authors:  Keith R Loeb; Bridget T Hughes; Brian M Fissel; Nyka J Osteen; Sue E Knoblaugh; Jonathan E Grim; Luke J Drury; Aaron Sarver; Adam J Dupuy; Bruce E Clurman
Journal:  Sci Rep       Date:  2019-04-02       Impact factor: 4.379

4.  A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional network.

Authors:  Ashwin Unnikrishnan; Yi F Guan; Yizhou Huang; Dominik Beck; Julie A I Thoms; Sofie Peirs; Kathy Knezevic; Shiyong Ma; Inge V de Walle; Ineke de Jong; Zara Ali; Ling Zhong; Mark J Raftery; Tom Taghon; Jonas Larsson; Karen L MacKenzie; Pieter Van Vlierberghe; Jason W H Wong; John E Pimanda
Journal:  Nucleic Acids Res       Date:  2016-09-06       Impact factor: 16.971

5.  Ets Related Gene and Smad3 Proteins Collaborate to Activate Transforming Growth Factor-Beta Mediated Signaling Pathway in ETS Related Gene-Positive Prostate Cancer Cells.

Authors:  Jinbo Fang; Huali Xu; Chunshu Yang; Sharif Morsalin; Shubhalaxmi Kayarthodi; Kunchala Rungsrisuriyachai; Ujwala Gunnal; Brittany Mckenzie; Veena N Rao; E Shyam P Reddy
Journal:  J Pharm Sci Pharmacol       Date:  2014-09-01

6.  Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia.

Authors:  Catherine L Carmichael; Donald Metcalf; Katya J Henley; Elizabeth A Kruse; Ladina Di Rago; Sandra Mifsud; Warren S Alexander; Benjamin T Kile
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-30       Impact factor: 11.205

7.  Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.

Authors:  Seiko Yoshino; Takashi Yokoyama; Yoshitaka Sunami; Tomoko Takahara; Aya Nakamura; Yukari Yamazaki; Shuichi Tsutsumi; Hiroyuki Aburatani; Takuro Nakamura
Journal:  Blood       Date:  2021-01-07       Impact factor: 22.113

8.  Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells.

Authors:  Ying Xie; Mia Lee Koch; Xin Zhang; Melanie J Hamblen; Frank J Godinho; Yuko Fujiwara; Huafeng Xie; Jan-Henning Klusmann; Stuart H Orkin; Zhe Li
Journal:  Stem Cells       Date:  2017-04-24       Impact factor: 6.277

Review 9.  The oncogene ERG: a key factor in prostate cancer.

Authors:  P Adamo; M R Ladomery
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

10.  ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia.

Authors:  Joost H A Martens; Amit Mandoli; Femke Simmer; Bart-Jan Wierenga; Sadia Saeed; Abhishek A Singh; Lucia Altucci; Edo Vellenga; Hendrik G Stunnenberg
Journal:  Blood       Date:  2012-09-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.